Q2 2022 Genomma Lab Internacional SAB de CV Earnings Call
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), today announced its results for the second quarter ended June 30, 2022. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS).
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, announces that the Company's Industrial Cluster has received EDGE (Excellence in Design for Greater Efficiencies) certification for each of its primary buildings: Pharmaceutical Plant, Personal Care Plant and Distribution Center.